NasdaqGS - Delayed Quote USD
Seres Therapeutics, Inc. (MCRB)
At close: 4:00 PM EST
After hours: 4:15 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ARKOWITZ DAVID A. Chief Financial Officer | Sale | Feb 16, 2024 | 182,442 |
| CLOGHESSY PAULA Officer | Sale | Oct 30, 2023 | 45,684 |
| DESROSIER THOMAS J J.D. Officer | Sale | Oct 28, 2024 | 133,414 |
| EGE DAVID S. Chief Technology Officer | Sale | Aug 16, 2024 | 77,575 |
| HENN MATTHEW R Officer | Sale | Oct 28, 2024 | 75,885 |
| SHAFF ERIC D Chief Executive Officer | Sale | Oct 28, 2024 | 165,082 |
| VON MOLTKE LISA M.D. Officer | Sale | Oct 28, 2024 | 30,423 |
| YOUNG TERESA L. Officer | Sale | Oct 28, 2024 | 88,483 |
Related Tickers
SYRS Syros Pharmaceuticals, Inc.
2.5600
+4.49%
SCPH scPharmaceuticals Inc.
4.3200
-0.46%
ARDX Ardelyx, Inc.
6.38
-1.69%
LYEL Lyell Immunopharma, Inc.
1.2200
-17.57%
BCTX BriaCell Therapeutics Corp.
0.7088
+0.54%
FGEN FibroGen, Inc.
0.3128
+0.77%
ALVR AlloVir, Inc.
0.9815
-2.82%
RAPT RAPT Therapeutics, Inc.
3.1000
+13.97%
ALT Altimmune, Inc.
7.46
+2.05%
SGMO Sangamo Therapeutics, Inc.
2.8100
+13.77%